- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 3, 2024 | 65.47M sh |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $540K |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $1.33M |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $67.97M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $0 |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $5.68M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $8.51M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $6.55M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $9.56M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $101.45M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $28.18M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $114.14M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $30.75M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $23.77M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $30.31M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 16.84M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $1K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$8.11M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $26.6M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $33.29M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.42 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.42 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $2.44M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $4.93M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$7.14M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$7.37M |